<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Initial treatment of pMMR/MSS, non-metastatic rectal adenocarcinoma</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Initial treatment of pMMR/MSS, non-metastatic rectal adenocarcinoma</h1>
<div class="graphic"><div class="figure"><div class="ttl">Initial treatment of pMMR/MSS, non-metastatic rectal adenocarcinoma</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">The initial management of pMMR/MSS non-metastatic rectal adenocarcinoma is presented here. The diagnosis must be pathologically confirmed on biopsy, and imaging and clinical studies should show no evidence of distant metastatic disease. Multidisciplinary treatment input is necessary from surgical oncology, radiation oncology, and medical oncology. For further details and evidence, refer to UpToDate content on the management of rectal adenocarcinoma.</div><div class="graphic_footnotes"><p>AJCC: American Joint Committee on Cancer; CT: computed tomography; CRT: chemoradiation; EUS: endoscopic ultrasound; M: metastasis; MRI: magnetic resonance imaging; MSS: microsatellite stable; N: node; pMMR: proficient mismatch repair; RT: radiation therapy; T: tumor.</p>
<p>* Clinical T1N0 and clinical T2N0 tumors are primarily managed with surgical resection (ie, transanal local excision, transabdominal resection).</p>
<p>Neoadjuvant CRT is an alternative for patients with a primary distal tumor who decline resection or are poor surgical candidates.</p>
<p>¶ Adjuvant therapy is indicated for clinical T1-2, N0 tumors treated with transabdominal resection that subsequently demonstrate pathologic T3-4 or pathologic N1-2 disease on postoperative pathology.</p>
<p>Δ Patients with a complete clinical response to total neoadjuvant therapy may be offered surveillance without further surgery.</p>
◊ Neoadjuvant chemotherapy plus response-guided use of RT allows most patients to omit RT and avoid its late toxicities. Patients treated with neoadjuvant chemotherapy who have a clinical response of 20% or greater for the primary tumor can omit RT and proceed directly to surgical resection, whereas those with a clinical response of less than 20% receive neoadjuvant CRT or RT prior to surgery.</div><div id="graphicVersion">Graphic 138397 Version 4.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
